Analysis of hyperglycemia management approaches is restricted to recipients of AKT, pan‐PI3k, and PI3K‐alpha targeting inhibitors who were not using antidiabetic drugs at cohort entry (n = 331). Here, AKT1 is linked to Hyperglycemia.